Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Michael H. Rosove, M.D.
Michael H. Rosove, M.D.

Specialty:

Cancer/Medical Oncology
Hematology
Internal Medicine

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Clinical Professor, Department of Medicine, Hematology/Oncology
Physician, Department of Medicine, Hematology/Oncology
Member, JCCC Cancer and Stem Cell Biology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:
Medicine, Hematology/Oncology, Columbia Presbyterian Medical Center, 1977 - 1978
Hematology/Oncology, UCLA School of Medicine, 1976 - 1979
Residency:
Internal Medicine, UCLA School of Medicine, 1974 - 1976
Internship:
Internal Medicine, UCLA School of Medicine, 1973 - 1974
Medical Degree:
M.D., UCLA School of Medicine, 1973

Certification(s):

Board Certification(s):
Hematology, American Board of Internal Medicine, 1982
Medical Oncology, American Board of Internal Medicine, 1981
Internal Medicine, American Board of Internal Medicine, 1976

Contact Information:

Phone:
(310) 206-6909 Hematology/Oncology information and patient appointments
(888) 662-8252 [(888) ONC-UCLA] Community Oncology Practice information and patient appointments
(310) 794-4955 Community Oncology Practice information
Email:

Practice Information:

Clinical Interest(s):
Hemostasis and thrombosis
General Hematology
Myeloproliferative and Myelodysplastic Disorders
Hematologic Malignancies
Head and Neck Cancer
Lung Cancer
General Medical Oncology

Scientific Interest(s):

Dr. Michael Rosove's research focuses on disorders of hemostasis and thrombosis, and he also has an interest in hematological malignancies and hepatocellular carcinoma.

Selected Cancer-Related Publications:

Marder VJ, Rosove MH, Minning DM. Foundation and sites of action of antithrombotic agents. Best Pract Res Clin Haematol. 2004 Mar;17(1):3-22.

Rosove MH. Platelet glycoprotein IIb/IIIa inhibitors. Best Pract Res Clin Haematol. 2004 Mar;17(1):65-76.

Salomon O, Zivelin A, Livnat T, Dardik R, Loewenthal R, Avishai O, Steinberg DM, Rosove MH, O'Connell N, Lee CA, Seligsohn U. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood. 2003 Jun 15;101(12):4783-8. Epub 2003 Feb 13.